A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.
Assiut Univeristy Hospital, Assiut, Egypt
CHU de Clermont-Ferrand, Clermont-Ferrand, France
Northwestern Memorial Hospital, Chicago, Illinois, United States
Geisinger Medical Center, Danville, Pennsylvania, United States
U of SC School of Medicine, Columbia, South Carolina, United States
Tulane University, New Orleans, Louisiana, United States
Hospital Jose Domingo de Obaldia, Chiriqui, Panama
Hospital Manuel Amador Guerrero, Colon, Panama
Complejo Hospitalario Caja de Seguro Social, Panamá, Panama
Hospital Santo Tomás, Panamá, Panama
Hospital Materno Infantil san Lorezo de las Minas, Santo Domingo, Dominican Republic
Hospital Universitario Maternidad Nuestra señoa de Alta Gracia, Santo Domingo, Dominican Republic
Queen Elizabeth Central Hospital, Blantyre, Malawi
Sevrance hospital, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.